发明授权
US08877812B2 Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
有权
婴幼儿，幼儿或儿童中坏死性小肠结肠炎，肠绞痛和短肠综合征发生率降低的方法
- 专利标题： Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
- 专利标题（中）： 婴幼儿，幼儿或儿童中坏死性小肠结肠炎，肠绞痛和短肠综合征发生率降低的方法
-
申请号： US13333936申请日： 2011-12-21
-
公开(公告)号： US08877812B2公开(公告)日： 2014-11-04
- 发明人: Chron-Si Lai , Keith A. Garleb , John B. Lasekan , Steven R. Davis
- 申请人： Chron-Si Lai , Keith A. Garleb , John B. Lasekan , Steven R. Davis
- 申请人地址： US IL Abbott Park
- 专利权人： Abbott Laboratories
- 当前专利权人： Abbott Laboratories
- 当前专利权人地址： US IL Abbott Park
- 代理机构： Calfee, Halter & Griswold LLP
- 主分类号： A61K31/19
- IPC分类号： A61K31/19 ; A61K31/20 ; A23D7/00 ; A23K1/16 ; A23K1/18 ; A23L1/30 ; A23L1/29
摘要：
Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
公开/授权文献
信息查询
